Latest news, press releases, and SEC filings for AN2 Therapeutics Inc (ANTX) https://caymanjournal.com/stock/ANTX en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 00:08:33 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 ⚠️ Analysis Blocked 🛑 I am ready to act as your expert financial analyst and educator! I understand the highly detailed structure, the conversational tone, and the requirement to surface every material detail while translating complex SEC filings into simple, actionable insights. **However, the a https://caymanjournal.com/stock/ANTX/sec-filing/0001193125-26-170328 https://caymanjournal.com/stock/ANTX/sec-filing/0001193125-26-170328 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **proxy statement (DEF 14A)** for AN2 Therapeutics. Think of it as the official "agenda packet" for the company's annual shareholder meeting. Its job is to give you all the information you need to vote on key decisions, even if you can't attend in person. * ** https://caymanjournal.com/stock/ANTX/sec-filing/0001193125-26-170314 https://caymanjournal.com/stock/ANTX/sec-filing/0001193125-26-170314 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing